ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today highlighted the scale and precision of its clinically integrate...

Industry’s largest provider network activates 1.2 million HCPs, supported by physician-level data and reporting
WHIPPANY, N.J.: ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today highlighted the scale and precision of its clinically integrated provider engagement network, spanning the full prescribing landscape – from the nation's leading health system EHRs to the outpatient and specialty settings where care is continuously delivered.
ConnectiveRx's network reaches more than 1.2 million providers inside workflows and at the point of care. Those interactions generate physician-level data (PLD) tied to actual prescribing activity, giving manufacturer and agency partners a real-world view of how providers engage and prescribe.
In terms of reaching an ideal prescriber base for a medication brand, major EHR platforms are a starting point, not a complete strategy. For specialty and chronic therapies, the majority of prescribing decisions occur in the ambulatory setting. It is not a new insight for ConnectiveRx; it is the foundation the network was built on. Manufacturer and agency partners benefit from the reach, targeting precision, and clinical context needed to engage priority HCPs where prescribing intent is actually highest.
“Medication brand messaging tied to therapeutic context, patient characteristics, and the act of prescribing itself has proven to increase first-fill rates and adherence to continued therapy," said ConnectiveRx SVP of Messaging Operations Lisa Prowker. "In-workflow messaging campaigns eclipse the performance of other channels, so our network is designed to ensure medication brands can engage providers across the full prescribing landscape, with the campaign transparency and data sophistication today's pharmaceutical partners expect.”
For more information, visit connectiverx.com.
About ConnectiveRx
ConnectiveRx is a leading technology-enabled pharmaceutical services company that provides patient and provider support, access, and adherence solutions for specialty and branded medications. The company’s services include the industry’s leading patient engagement and access platform (hub services), patient and provider adherence messaging, patient affordability programs, and the iconic Physicians’ Desk Reference, now known as the Prescribers’ Digital Reference. ConnectiveRx’s wide array of services and innovative solutions accelerate speed-to-therapy and increase access and adherence, resulting in improved outcomes for patients and healthcare overall. To learn more, visit www.connectiverx.com or follow us on LinkedIn @ConnectiveRx.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) (“Palladyne AI”), a U.S.-based defense and industrial technology company delivering embodied AI-powered collaborative…
Advocacy, the AI-native, context-first litigation workspace, today emerged from stealth and announced it has raised $3.5 million in seed funding. The…
Turkcell Iletisim Hizmetleri A.S. (NYSE:TKC) (BIST:TCELL): Please note that all financial data is consolidated and comprises that of Turkcell İletişim…
Conduent Incorporated (Nasdaq: CNDT), a global technology-driven business solutions and services company, today announced the appointment of Greta Van…